Biochemistry Experts

Leadxpro Ag

CEO and Chairman
Structural Biology
University of Basel


Michael Hennig is a drug discovery Research Manager with 22 years of experience in pharmaceutical industry. He co-founded and is CEO and Chairman of the board of LeadXpro AG, an emerging biotech company and spin-out of the Paul Scherrer Institute (ETH, Switzerland) that is dedicated to structure based drug discovery of membrane protein targets. Formerly he worked 20 years at Roche research Basel as Global Head and Principle Leader of discovery technologies with responsibility for structure based drug discovery, protein science, assay development and HTS, corporate compound library, stem cell platform. In addition, he is guest Professor at the University of Basel in Structural Biology, gives lecture series in pharmacy, is author of more than 75 paper and lecturer at conferences, inventor of 8 patents in areas of technology, discovery and formulation of drug substances.

Research Interest

drug discovery


  • Structure based drug discovery on membrane protein targets: New developments and advancements

Global Experts from Swaziland

Global Experts in Subject

Share This Profile
Recommended Conferences
  • 3rd International Conference on Molecular Biology & Nucleic Acids August 27-28, 2018 Toronto, Ontario, Canada Theme: Molecular Biology & Nucleic Acids - The Blueprint of Life

    August 27-28, 2018 Toronto, Canada

  • 4th International Conference on Biochemistry & Biophysics October 03-04, 2018 Los Angeles, California, USA Theme: Lets Make Every Molecules Count

    October 03-04, 2018 Los Angeles, USA

  • International conference on Biomolecules, Membrane Sciences and Technologies October 16-17, 2018 Ottawa, Ontario, Canada Theme: Biomolecules- A Connecting Innovation in Science

    October 16-17, 2018 Ottawa, Canada

View more